Search Results for: Ash dischargers
at the q1 2010 investor conference call. followed by a discussion. february 26, 2010, fy/q4 2009 investor conference call werner wenning, ceo of bayer ag, at the fy/q4 2009 investor conference call. followed by a discussion. december 8, 2009, investor conference call - rivaroxaban data at the 2009 ash
annual meeting investor conference call: data for rivaroxaban have been presented at the 2009 ash annual meeting. presentation followed by a discussion. october 27, 2009, q3 2009 investor conference call werner wenning, ceo of bayer ag, at the q3 2009 investor conference call. followed by a discussion...
http://www.podcast.bayer.com/module/podcast/investor.xml